✦ LIBER ✦

N-(Phosphonacetyl)-l-aspartate (PALA) in advanced malignant melanoma: A phase II trial of the EORTC malignant melanoma cooperative group

✍ Scribed by Kleeberg, U.R.; Mulder, J.H.; Rümke, P.; Thomas, D.; Rozencweig, M.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

N-(Phosphonacetyl)-l-aspartate (PALA) in

✍ van Oosterom, A.; Rotmensz, N.; Sylvester, R.; Heuson, J.C.; Rozencweig, M.; Par 📂 Article 📅 1982 🏛 Elsevier Science ⚖ 474 KB

Combination of cisplatin, vindesine, and

✍ C. F. Verschraegen; U. R. Kleeberg; J. Mulder; P. Rumke; F. Truchetet; B. Czarne 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 503 KB

N-(Phosphonacetyl)-l-aspartate (PALA) in

✍ Bramwell, V.; van Oosterom, A.; Mouridsen, H.T.; Cheix, F.; Somers, R.; Thomas, 📂 Article 📅 1982 🏛 Elsevier Science ⚖ 468 KB

Docetaxel (Taxotere) in advanced maligna

✍ Aamdal, S.; Wolff, I.; Kaplan, S.; Paridaens, R.; Kerger, J.; Schachter, J.; Wan 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 536 KB

Taxotere in advanced malignant melanoma:

✍ Aamdal, S.; Verweij, J.; Piccart, M.; Bruntsch, U.; Paridaens, R.; Sulkes, A.; K 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 170 KB

Results of a phase II trial with cystemu

✍ V. Urosevic; Ph. Chollet; A. Adenis; J. Chauvergne; P. Fargeot; H. Roche; P. Ker 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 279 KB